Genflow Biosciences Plc Financial Overview
Genflow Biosciences Plc's market cap is currently £8.88M. The company's EPS TTM is p-0.002; its P/E ratio is -3.60; Genflow Biosciences Plc is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
